Literature DB >> 22753860

Monitoring cardiometabolic risk in schizophrenia.

Hellme Najim.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22753860     DOI： 10.1192/bjp.201.1.75b

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  2 in total

1.  Screening for the metabolic side effects of antipsychotic medication: findings of a 6-year quality improvement programme in the UK.

Authors:  T R E Barnes; S F Bhatti; R Adroer; C Paton
Journal:  BMJ Open       Date:  2015-10-01       Impact factor: 2.692

2.  Monitoring of somatic parameters at outpatient departments for mood and anxiety disorders.

Authors:  Mirjam Simoons; Hans Mulder; Bennard Doornbos; Robert A Schoevers; Eric N van Roon; Henricus G Ruhé
Journal:  PLoS One       Date:  2018-08-21       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.